Increased secretion of erythropoietin in human renal carcinoma cells in response to atrial natriuretic factor.
The present studies were undertaken to assess the effects of atrial natriuretic factor (ANF) on erythropoietin (Ep) secretion in Ep-producing renal carcinoma (RC) cells using a sensitive radioimmunoassay for Ep. Human ANF produced a significant dose-related increase in Ep secretion at concentrations of 10(-7) and 10(-6) M when compared with vehicle controls. ANF (greater than or equal to 10(-9) M) also significantly increased the intracellular guanosine 3',5'-cyclic monophosphate (cGMP) concentration after 5-min incubation with the RC cells. Scatchard analysis of the human 125I-labeled ANF binding data indicated that the RC cells contain a single class of binding sites with a dissociation constant (Kd) of 93 +/- 1 pM and a binding capacity of 2,190 +/- 750 sites/cell. Incubation of the RC cells with 8-bromo-cGMP in concentrations of 10(-7)-10(-5) M also produced a significant dose-related enhancement of Ep secretion. These findings suggest that the increase in Ep secretion in response to ANF can be attributed, at least in part, to activation of guanylate cyclase, which is coupled to specific ANF receptors on the RC cell.
Ueno
M
M
Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana 70112.
Rondon
I
I
Beckman
B
B
Brookins
J
J
Nakashima
J
J
Cole
F E
FE
Fisher
J W
JW
D009320:Atrial Natriuretic Factor / Q000494:pharmacology*; D002292:Carcinoma, Renal Cell / Q000503:physiopathology*; D006152:Cyclic GMP / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D004921:Erythropoietin / Q000378:metabolism*; D006801:Humans; D007680:Kidney Neoplasms / Q000503:physiopathology*; D007700:Kinetics; D008175:Lung Neoplasms / Q000503:physiopathology / Q000556:secondary; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000502:physiology
C472955:NPPA protein, human; D004921:Erythropoietin; C016276:8-bromocyclic GMP; D009320:Atrial Natriuretic Factor; D006152:Cyclic GMP